Genetica is a San Francisco-founded gene decoding company built for Asian genomes. It pairs a proprietary genotyping chip - manufactured with Illumina and Thermo Fisher - with AI analysis to turn a saliva sample into reports on health risks, innate ability, behavior, nutrition and fitness. Marketed direct-to-consumer across Vietnam and Southeast Asia, its CLIA- and CAP-certified pipeline is reviewed by scientists tied to UCSF, Harvard, Stanford and Cornell.
Tiny Health is an Austin-based health company that built the first at-home gut microbiome test designed for babies, then extended the same clinically-validated science to children, pregnant people, adults and longevity. It pairs DNA sequencing of stool and vaginal samples with age-specific reference ranges and personalized, research-backed recommendations, aiming to catch early microbiome imbalances linked to eczema, allergies, digestive issues and chronic conditions before they take hold.
Signos is a San Francisco Bay Area digital health company pairing a continuous glucose monitor with an AI-driven app to help non-diabetic adults lose weight and improve metabolic health through real-time, personalized feedback on food, sleep, stress and exercise.
Vivoo is a San Francisco-based health tech company that makes at-home urine test strips analyzed via smartphone camera. Founded in 2017, the company offers a wellness platform that measures 8+ biomarkers — including hydration, vitamins, minerals, pH, ketones, and oxidative stress — and delivers personalized nutrition and lifestyle recommendations through a free mobile app. Backed by $19.4M in funding led by Tim Draper, Vivoo is sold at Target, Walmart, and Sam's Club, and has expanded to 100+ countries with a focus on making lab-grade health insights accessible to everyday consumers.